M6A-dependent RNA condensation underlies FUS autoregulation and can be harnessed for ALS therapy development
Science Advances · 2025
DOI: 10.1126/sciadv.adx1357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Wan-Ping Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Sheffield Institute for Translational Neuroscience (SITraN) and Neuroscience Institute, University of Sheffield, Sheffield, UK. Hauptthemen laut MEDLINE: RNA-Binding Protein FUS, Amyotrophic Lateral Sclerosis, Adenosine, RNA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Mutations in the FUS gene cause aggressive amyotrophic lateral sclerosis (ALS-FUS). Beyond mRNA, FUS generates partially processed transcripts retaining introns 6 and 7. We demonstrate that these FUSint6&7-RNA molecules form nuclear condensates, scaffolded by the highly structured intron 7 and associated with nuclear speckles. Using hybridization-proximity labeling proteomics, we show that the FUSint6&7-RNA condensates are enriched for splicing factors and the N6-methyladenosine (m6A) reader YTHDC1. These ribonucleoprotein structures facilitate posttranscriptional FUS splicing and depend on m6A/YTHDC1 for integrity. In cells expressing mutant FUS, FUSint6&7-RNAs become hypermethylated, which in turn stimulates their condensation and splicing. We further show that FUS protein is repelled by m6A. Thus, ALS-FUS mutations may cause abnormal activation of FUS posttranscriptional splicing through altered RNA methylation. Notably, ectopic expression of FUS intron 7 sequences dissolves endogenous FUSint6&7-RNA condensates, down-regulating FUS mRNA and protein. Our findings reveal a condensation-dependent mechanism regulating FUS splicing, with possible therapeutic implications for ALS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sheffield Institute for Translational Neuroscience (SITraN) and Neuroscience Institute, University of Sheffield, Sheffield, UK.
- Centre for Developmental Biology, King's College London, London, UK.
- Medical School, Swansea University, Swansea, UK.
- Institute of Molecular Biosciences, Goethe University, Frankfurt am Main, Germany.
ORCID-Profile: Wan-Ping Huang, Vedanth Kumar, Haiyan An, Sabin J John, Rachel E Hodgson, Emily Day, Tek Hong Chung, Jenny Lord, Michaela Müller-McNicoll, Eugene V Makeyev, Tatyana A Shelkovnikova
Zitieren
APA
Huang, W. P., Kumar, V., Yap, K., An, H., John, S. J., Hodgson, R. E., Avila, A. S., Day, E., Ellis, B. C. S., Chung, T. H., Lord, J., Müller-McNicoll, M., Makeyev, E. V., & Shelkovnikova, T. A. (2025). M6A-dependent RNA condensation underlies FUS autoregulation and can be harnessed for ALS therapy development. Science Advances. https://doi.org/10.1126/sciadv.adx1357
Vancouver
Huang WP, Kumar V, Yap K, An H, John SJ, Hodgson RE, et al. M6A-dependent RNA condensation underlies FUS autoregulation and can be harnessed for ALS therapy development. Science Advances. 2025. doi:10.1126/sciadv.adx1357
BibTeX
@article{Huang2025,
author = {Huang, Wan-Ping and Kumar, Vedanth and Yap, Karen and An, Haiyan and John, Sabin J and Hodgson, Rachel E and Avila, Anna Sanchez and Day, Emily and Ellis, Brittany C S and Chung, Tek Hong and Lord, Jenny and Müller-McNicoll, Michaela and Makeyev, Eugene V and Shelkovnikova, Tatyana A},
title = {M6A-dependent RNA condensation underlies FUS autoregulation and can be harnessed for ALS therapy development},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adx1357}
}
EUVIMED